FibroGen Investors
FibroGen is a venture capital fund based in San Francisco, California, founded in 1993 The firm focuses on investing in innovative biotechnology and pharmaceutical companies With a significant investment scale of $145,800,000, FibroGen aims to support the development of breakthrough therapies The fund is dedicated to advancing healthcare solutions that address unmet medical needs Through strategic partnerships and investments, FibroGen seeks to drive growth and innovation within the life sciences sector
Investors
Employee Number:
251-500
Funding Status:
IPO
Headquarters:
USA
Technology:
Drug Delivery
Estimated Revenue:
$10M to $50M
Founded Date:
1993
Investor Type:
Venture Capital Funds
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
FemTech